Table S1 - Clinical Characteristics with an Impact on ADL Functions of PD Patients with Cognitive Impairment Indicative of Dementia

Neuropsychological assessment PD patients with cognitive impairment indicative for Parkinson’s disease dementia (PDD) who were rated by their caregivers as having an ADL impairment (ADL- ) or not (ADL+) after the exclusion of patients with major depression (n=2 ADL+, n=5 ADL-). Table S1 shows the replication of the main analysis after excluding patients with major depression (n=2, ADL+; n=4, ADL-) or undefined status of depression (n=1, ADL-). Values are given as median and range (minimum-maximum). Mean group performances are given in relation to the standardized values provided by the test manuals with lower values indicating poorer test performances. Only for the Berlin Apraxia Test raw data are presented. ADL: Activities of Daily Living.; PANDA: Parkinson Neuropsychometric Dementia Assessment; PD: Parkinson's Disease; PDD: Parkinson's Disease Dementia; p: Level of significance; N: number. (DOCX)